LI
SGNT

LMCG Investments’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

LMCG Investments’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$301K Buy
19,664
+1,737
+10% +$37.5K 0.01% 502
2015
Q2 		$436K Buy
17,927
+5,115
+40% +$123K 0.01% 477
2015
Q1 		$298K Buy
+12,812
New +$339K 0.01% 517

Other funds holding SGNT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LMCG Investments's SGNT Position: Q3 2015 in Review

LMCG Investments increased its SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) stake by 9.7% in Q3 2015, buying an estimated $37.5K and bringing the position to 19,664 shares worth $301K. The position accounts for 0.01% of the portfolio, ranked #502.

LMCG Investments first reported a position in SGNT in Q1 2015 and has held it in 3 quarters since. The position peaked at $436K in Q2 2015. 127 funds tracked by Wall St. Rank hold SGNT as of Q3 2015.

  • LMCG Investments held 19,664 shares of SAGENT PHARMACEUTICALS INC COM STK (DE) worth $301K as of Q3 2015.
  • LMCG Investments bought 1,737 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2015, an estimated $37.5K.
  • SAGENT PHARMACEUTICALS INC COM STK (DE) made up 0.01% of LMCG Investments's portfolio in Q3 2015, its #502 holding.
  • LMCG Investments first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and has held it in 3 quarters since.
  • LMCG Investments's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $436K in Q2 2015.
  • 127 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2015.

Based on LMCG Investments's 13F filing for Q3 2015, filed 4 Nov 2015.